Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidiolex® For The Treatment Of Anxiety Comorbidity in Refractory Pediatric Epilepsy

NCT05324449 is registered in ClinicalTrials.gov with Hugo W. Moser Research Institute at Kennedy Krieger, Inc. as lead sponsor.

NCT NCT05324449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05324449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidiolex® For The Treatment Of Anxiety Comorbidity in Refractory Pediatric Epilepsy
Lead sponsor
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Phase
Phase 4
Overall status
Completed
Start date
April 5, 2022
Completion date
May 5, 2025
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, epilepsy